ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,243Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 349

$1.18M Total Retail Price of All Prescriptions

Rank: 7 out of 349

1,049 Patients Receiving at Least One Drug in Part D
27%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

75% of this provider’s 1,049 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

27% of this provider’s 1,049 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

6% of this provider’s 3,005 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$97 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OXYCODONE HCL 1,935 440 S2 1 15
HYDROCODONE-ACETAMINOPHEN 1,073 481 S3 2 2
GABAPENTIN 955 232 3 8
TIZANIDINE HCL 841 145 4 40
ZOLPIDEM TARTRATE 494 147 5 13
CYCLOBENZAPRINE HCL 487 104 R 6 34
OXYCODONE HCL-ACETAMINOPHEN 460 150 S2 7 27
OXYCONTIN 448 77 S2 8 58
LYRICA 336 67 9 63
OPANA ER 313 16 S2 10 80
CYMBALTA 312 78 11 45
MORPHINE SULFATE ER 279 44 S2 12 38
VENLAFAXINE HCL ER 275 71 13 94
LIDODERM 237 94 14 145
PROMETHAZINE HCL 235 37 R 15 84
DICLOFENAC SODIUM 228 47 16 111
TRAZODONE HCL 218 40 17 29
FENTANYL 200 68 S2 18 51
ENDOCET 200 45 S2 18 52
OMEPRAZOLE 163 46 20 1
OXYCODONE-ACETAMINOPHEN 152 69 S2 21 26
MELOXICAM 144 17 22 37
BACLOFEN 117 14 23 162
METHADONE HCL 106 13 S2 24 65
MORPHINE SULFATE 100 21 S2 25 132
VOLTAREN 94 16 26 182
CITALOPRAM HBR 89 0 27 18
AMITRIPTYLINE HCL 80 15 R 28 79
CELEBREX 77 41 29 167
IBUPROFEN 76 19 30 99
LUNESTA 74 23 31 234
ORPHENADRINE CITRATE 66 13 R 32 251
VENLAFAXINE HCL 63 0 33 259
ABILIFY 63 19 33 69
NEXIUM 63 0 33 20
TRAMADOL HCL 59 26 36 16
OXYMORPHONE HCL 50 0 S2 37 289
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.